New Post Public Reply Private Reply Replies (0) Message Board ← Newer Older → News Desk 2018 Apr 19, 2018 at 6:45 AM 175 Provectus Biopharmaceuticals, Inc. (PVCT: OTCQB) | SECOND STUDY OF EXPANDED ACCESS PATIENTS TREATED WITH PV-10 FOR IN-TRANSIT MELANOMA PUBLISHED IN JOURNAL OF SURGICAL ONCOLOGY Newer Older
